Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience
Journal Title: Heart Research – Open Journal - Year 2017, Vol 4, Issue 3
Abstract
Objective: The aim of the study was to test both efficacy and safety of empaglifozin in type 2 diabetic out patients followed-up within a single institution. Materials and Methods: One hundred seventy-eight consecutive patients treated with empaglifozin for 6 months were compared to 356 fully matched control patients on alternative drugs: side effects were monitored and changes from baseline were evaluated for body weight, body mass index (BMI), blood pressure, circulating glucose, HbA1c, uric acid, triglycerides, total, high density lipoprotein (HDL) and low density lipoprotein (LDL)-cholesterol levels, as well as creatinine clearance rate. The 10-year Cardiovascular Risk score (10-y CV-RS) was also assessed in all patients according to the cryogenic underground observatory for rare events (CUORE) calculation charts. Weight, BMI, systolic and diastolic blood pressure, as well as, HbA1c, glucose, cholesterol, triglyceride and uric acid levels, significantly decreased after treatment, along with the 10-y CV-RS which is in fact strongly related to the above. Results: Virtually no changes were observed in creatinine clearance rate and HDL levels. 45% patients reported polyuria, 15% genital itching, 8% genital infections, 12% urinary tract infections, no volume depletion or keto-acidosis episodes were described. Conclusion: In conclusion, in diabetic patients experiencing no previous major cardiovascular events, empaglifozin significantly improved all cardiovascular risk factors, including glucose control, and the 10-y CV-RS. Moreover it was well tolerated, so that no treatment discontinuation was needed even in case of urinary tract infections.
Authors and Affiliations
Sandro Gentile
Keywords
Related Articles
- EP ID EP557960
- DOI 10.17140/HROJ-4-141
- Views 132
- Downloads 0
The PLATFORM Trial: An Insight into the Improved Value of Using FFRCT for Reduction of Invasive Angiographic Procedures
Coronary CT Angiography (CCTA) has been widely used as a reliable non-invasive modality for the diagnosis of Coronary Artery Disease (CAD) due to its improved spatial and temporal resolution.1-5For patients with low to i...
Cardiac Telerehabilitation - Current State and Clinical Perspectives
Cardiovascular Diseases (CVD) are regarded as a leading cause of death globally, constituting important medical, social and economical problem. Systematic reviews and metaanalyses show the positive effect of exercise-bas...
Clinical Characteristics of Children with Pulmonary Vein Abnormalities in a Tertiary Centre in an Urban Community in Nigeria
Background: Pulmonary vein abnormalities are rare. Prompt intervention is needed to salvage the children affected. There are very few reports on occurrence of pulmonary vein abnormalities among Nigerian and African child...
Primary Angioplasty Using a Renal Stent in a Severly Ectactic and Occluded Left Anterior Descending Coronary Artery
Revascularization of ectatic coronary arteries in the setting of acute myocardial infarction poses great challenges for the operator. We report a case, where a peripheral renal stent was used successfully to treat the cl...
A Decade of Lipid Profiles: A Gender Focus
Introduction and Objectives: The lipid profile is an important predictor of the risk of coronary heart disease (CHD). Higher rates of total cholesterol (TC) and cholesterol of low-density lipoprotein (LDL-C) increase the...